BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 23903553)

  • 1. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.
    Damiani C; Le Gal S; Da Costa C; Virmaux M; Nevez G; Totet A
    J Clin Microbiol; 2013 Oct; 51(10):3380-8. PubMed ID: 23903553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization.
    Matsumura Y; Ito Y; Iinuma Y; Yasuma K; Yamamoto M; Matsushima A; Nagao M; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2012 Jun; 18(6):591-7. PubMed ID: 21973089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum (1 → 3) β-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonization.
    Tasaka S; Kobayashi S; Yagi K; Asami T; Namkoong H; Yamasawa W; Ishii M; Hasegawa N; Betsuyaku T
    J Infect Chemother; 2014 Nov; 20(11):678-81. PubMed ID: 25066434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of (1,3) ß-D-glucan detection in bronchoalveolar lavage samples in Pneumocystis pneumonia and Pneumocystis pulmonary colonization.
    Damiani C; Le Gal S; Goin N; Di Pizio P; Da Costa C; Virmaux M; Bach V; Stéphan-Blanchard E; Nevez G; Totet A
    J Mycol Med; 2015 Mar; 25(1):36-43. PubMed ID: 25498852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients.
    Fauchier T; Hasseine L; Gari-Toussaint M; Casanova V; Marty PM; Pomares C
    J Clin Microbiol; 2016 Jun; 54(6):1487-1495. PubMed ID: 27008872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-d-Glucan for Diagnosing
    Mercier T; Guldentops E; Patteet S; Beuselinck K; Lagrou K; Maertens J
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30918045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii.
    Louis M; Guitard J; Jodar M; Ancelle T; Magne D; Lascols O; Hennequin C
    J Clin Microbiol; 2015 Dec; 53(12):3870-5. PubMed ID: 26468505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients.
    Huggett JF; Taylor MS; Kocjan G; Evans HE; Morris-Jones S; Gant V; Novak T; Costello AM; Zumla A; Miller RF
    Thorax; 2008 Feb; 63(2):154-9. PubMed ID: 17693588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study.
    Hammarström H; Grankvist A; Broman I; Kondori N; Wennerås C; Gisslen M; Friman V
    BMC Infect Dis; 2019 Jul; 19(1):658. PubMed ID: 31337356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients.
    Maillet M; Maubon D; Brion JP; François P; Molina L; Stahl JP; Epaulard O; Bosseray A; Pavese P
    Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):331-6. PubMed ID: 23990137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients.
    Alanio A; Desoubeaux G; Sarfati C; Hamane S; Bergeron A; Azoulay E; Molina JM; Derouin F; Menotti J
    Clin Microbiol Infect; 2011 Oct; 17(10):1531-7. PubMed ID: 20946413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients.
    Rogina P; Skvarc M
    Radiol Oncol; 2020 May; 54(2):221-226. PubMed ID: 32463392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients.
    Botterel F; Cabaret O; Foulet F; Cordonnier C; Costa JM; Bretagne S
    J Clin Microbiol; 2012 Feb; 50(2):227-31. PubMed ID: 22162560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Evaluation of a Fully Automated Molecular Assay Targeting the Mitochondrial Small Subunit rRNA Gene for the Detection of Pneumocystis jirovecii in Bronchoalveolar Lavage Fluid Specimens.
    Liu B; Totten M; Nematollahi S; Datta K; Memon W; Marimuthu S; Wolf LA; Carroll KC; Zhang SX
    J Mol Diagn; 2020 Dec; 22(12):1482-1493. PubMed ID: 33069878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of quantitative FTD-Pneumocystis jirovecii kit for Pneumocystis infection diagnosis.
    Hoarau G; Le Gal S; Zunic P; Poubeau P; Antok E; Jaubert J; Nevez G; Picot S
    Diagn Microbiol Infect Dis; 2017 Nov; 89(3):212-217. PubMed ID: 28851493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of quantitative PCR to discriminate
    Perret T; Kritikos A; Hauser PM; Guiver M; Coste AT; Jaton K; Lamoth F
    J Med Microbiol; 2020 May; 69(5):705-711. PubMed ID: 32369002
    [No Abstract]   [Full Text] [Related]  

  • 17. The Fungal PCR Initiative's evaluation of in-house and commercial Pneumocystis jirovecii qPCR assays: Toward a standard for a diagnostics assay.
    Gits-Muselli M; White PL; Mengoli C; Chen S; Crowley B; Dingemans G; Fréalle E; L Gorton R; Guiver M; Hagen F; Halliday C; Johnson G; Lagrou K; Lengerova M; Melchers WJG; Novak-Frazer L; Rautemaa-Richardson R; Scherer E; Steinmann J; Cruciani M; Barnes R; Donnelly JP; Loeffler J; Bretagne S; Alanio A
    Med Mycol; 2020 Aug; 58(6):779-788. PubMed ID: 31758173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.
    Esteves F; Lee CH; de Sousa B; Badura R; Seringa M; Fernandes C; Gaspar JF; Antunes F; Matos O
    Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1173-80. PubMed ID: 24487911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia.
    Matsumura Y; Ito Y; Yamamoto M; Matsushima A; Nagao M; Takakura S; Iinuma Y; Ichiyama S
    J Infect Chemother; 2014 Feb; 20(2):109-14. PubMed ID: 24480550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.
    Robert-Gangneux F; Belaz S; Revest M; Tattevin P; Jouneau S; Decaux O; Chevrier S; Le Tulzo Y; Gangneux JP
    J Clin Microbiol; 2014 Sep; 52(9):3370-6. PubMed ID: 25009050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.